Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Otsuka sells prescription medicines, nutraceuticals, and everyday consumer products like water, beverages, and food to people and medical facilities around the world.
Otsuka is a Japanese health care and consumer goods company. It makes prescription medicines for serious illnesses, sells nutraceuticals and over-the-counter products, and runs a big consumer business selling bottled water, beverages, and food. You will find its products in hospitals and pharmacies, but also in convenience stores and supermarkets, which is unusual for a drugmaker.

The pharmaceutical arm is the engine. Its best-known medicine is Abilify, an antipsychotic that became a global blockbuster and, for a stretch, one of the world's biggest-selling drugs. Otsuka also sells treatments for kidney disease, cancer, and central nervous system conditions, often partnering with larger drugmakers to reach more patients. The company spends heavily on research, because drug patents eventually expire and sales fall off a cliff when cheaper generics arrive. The consumer side gives Otsuka a steadier, less glamorous stream of money. Its Pocari Sweat sports drink is a household name across Asia, and the company sells bottled water, food, and other daily products. This business is lower-margin but reliable, and it keeps cash coming in even when a drug patent runs out.
Otsuka is headquartered in Tokyo and has grown largely by buying other companies and striking partnerships rather than staying a pure Japanese drugmaker. It also owns a stake in a nutraceutical business and has expanded into the United States and Europe. The appeal to investors is the mix: risky, high-reward drug research balanced by the boring, dependable sale of drinks and snacks.
Saved answer · last researched 12 Nov 2026